Company news
Acumen Pharmaceuticals, Inc. news in 2022
Acumen Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights
November 13, 2022
Acumen Pharmaceuticals to Report Third Quarter 2022 Financial Results on Nov. 14, 2022
November 6, 2022
Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for Alzheimer's Disease
October 23, 2022
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2022 and Business Highlights
August 14, 2022
Acumen Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 15, 2022
August 7, 2022
Acumen Pharmaceuticals Reports Financial Results for First Quarter 2022 and Business Highlights
May 15, 2022
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business Highlights
March 27, 2022
Acumen Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on March 28, 2022
March 15, 2022
Calls in 2022
- Acumen Pharmaceuticals (NASDAQ:ABOS) Q3 2022 Earnings Call
Nov 14, 2022
Transcript - Acumen Pharmaceuticals (NASDAQ:ABOS) Q2 2022 Earnings Call
Aug 15, 2022
Transcript - Acumen Pharmaceuticals (NASDAQ:ABOS) Q1 2022 Earnings Call
May 16, 2022
Transcript - Acumen Pharmaceuticals (NASDAQ:ABOS) Q4 2021 Earnings Call
Mar 28, 2022
Transcript
Decks in 2022
- Investor Presentation (November 2022)
Investor deck · 35 slides · Nov 14, 2022
- Q3 2022 Earnings Presentation
Earnings · 6 slides · Nov 14, 2022
- Investor Presentation (September 2022)
Investor deck · 35 slides · Sep 12, 2022
- FY 2021 Earnings Presentation
Earnings · 11 slides · Mar 28, 2022